A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis

Oleg Timofeev1, Ting Yi Lee, Dmitry V Bulavin

  • 1Cell Cycle Control and Tumorigenesis Group, Institute of Molecular and Cell Biology, Singapore.

Insights

Subtle activation of p38 mitogen-activated protein kinase (MAPK) suppresses tumor formation. This finding suggests new anti-cancer drug screening methods beyond traditional cell growth inhibition assays.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Emerging evidence suggests p38 MAPK plays a role in suppressing tumor development.
  • Understanding the precise role of p38 MAPK in tumorigenesis is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the effect of subtle p38 MAPK activation on tumorigenesis.
  • To explore novel anti-cancer drug screening methodologies.

Main Methods:

  • Utilized MKK6-inducible cells explanted into nude mice to assess tumor formation.
  • Employed standard MTS assays to measure in vitro cell growth inhibition.

Main Results:

  • A subtle activation of p38 MAPK was sufficient to suppress tumor formation in vivo.
  • This activation did not necessarily lead to immediate inhibition of cell growth in vitro.

Conclusions:

  • p38 MAPK activation can suppress tumorigenesis independently of immediate cell growth inhibition.
  • This highlights a potential limitation in current high-throughput screening assays for anti-cancer compounds.
  • Suggests activators of MKK6/p38 signaling as potential anti-tumor agents missed by conventional assays.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...